Role of Tumor Necrosis Factor in Tuberculosis
Biomolecules · 12.05.2025 · 15 (5) · 709
DOI: 10.3390/biom15050709 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 12.05.2025. Verfasst von Fedor D Kireev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI…. Hauptthemen laut MEDLINE: Tuberculosis, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 329 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Tumor necrosis factor (TNF) is a key immunoregulatory cytokine with a dual role in the host response to Mycobacterium tuberculosis. While essential for granuloma formation, macrophage activation, and containment of latent infection, TNF can also contribute to tissue damage and immune pathology. This review systematically analyzes over 300 peer-reviewed studies published between 1980 and 2024, highlighting the molecular and cellular mechanisms of TNF action in tuberculosis (TB). Particular attention is given to TNF receptor signaling pathways, the balance between protective and pathological immune responses, and the modulation of TNF activity during anti-TNF therapy in patients with autoimmune diseases. We discuss how different TNF inhibitors vary in their capacity to interfere with host defense mechanisms, with monoclonal antibodies carrying a higher reactivation risk than receptor-based agents. To enhance conceptual clarity, we provide newly developed schematic representations that integrate current knowledge on TNF-driven immune dynamics, including its interaction with other cytokines, effects on granuloma stability, and role in intracellular bacterial control. Understanding the pleiotropic functions of TNF in tuberculosis pathogenesis is crucial for developing safe immunomodulatory strategies and optimizing the clinical management of patients at risk of latent TB reactivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), 630099 Novosibirsk, Russia.
- Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education "I.M. Sechenov First Moscow State Medical University" under the Ministry of Health of the Russian Federation (Sechen…
ORCID-Profile: Fedor D Kireev, Julia A Lopatnikova, Alina A Alshevskaya, Sergey V Sennikov
Förderung
- Russian Science Foundation
Zitieren
APA
Kireev, F. D., Lopatnikova, J. A., Alshevskaya, A. A., & Sennikov, S. V. (2025). Role of Tumor Necrosis Factor in Tuberculosis. Biomolecules, 15(5), 709. https://doi.org/10.3390/biom15050709
Vancouver
Kireev FD, Lopatnikova JA, Alshevskaya AA, Sennikov SV. Role of Tumor Necrosis Factor in Tuberculosis. Biomolecules. 2025;15(5):709. doi:10.3390/biom15050709
BibTeX
@article{Kireev2025,
author = {Kireev, Fedor D and Lopatnikova, Julia A and Alshevskaya, Alina A and Sennikov, Sergey V},
title = {Role of Tumor Necrosis Factor in Tuberculosis},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {5},
pages = {709},
doi = {10.3390/biom15050709}
}
EUVIMED